Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Suspected Ecthyma Gangrenosum Associated with Methicillin-Sensitive Staphylococcus Aureus Bacteremia

Austin Hamp*, Nate Hansen, Jamila Asif, Jarett Anderson, Arjun Bal, Cecilia Big, Wehbi Hanayni

Arizona College of Osteopathic Medicine, Glendale, Arizona

Abstract: Ecthyma gangrenosum (EG) is a well-recognized but rare skin infection most commonly occurring in the setting of immunocompromised individuals with bacteremia. Currently, there are very few reports of EG caused by methicillin-resistant Staphylococcus aureus (MRSA) and even fewer cases caused by methicillin-sensitive Staphylococcus aureus (MSSA). We present only the second case of bacteremic EG associated with MSSA bacteremia and aim to review the literature as well as examine common findings amongst patients with EG associated with Staphylococcus aureus.

Keywords: Ecthyma gangrenosum, Staphylococcus aureus, MRSA, MSSA, bacteremia

Received March 22, 2023; Revised April 25, 2023; Accepted May 14, 2023

Citation: Austin Hamp, Nate Hansen, Jamila Asif, Jarett Anderson, Arjun Bal, Cecilia Big, Wehbi Hanayni, Suspected Ecthyma Gangrenosum Associated with Methicillin-Sensitive Staphylococcus Aureus Bacteremia. American Journal of Medical Case Reports, 11 (5). 86-89. January 2023. doi:10.12691/ajmcr-11-5-1

1. Introduction

Ecthyma gangrenosum (EG) is a well-recognized but rare skin infection most commonly occurring in the setting of immunocompromised individuals. Pseudomonas aeruginosa is the most frequent organism identified in EG. In rare cases, it may be caused by other bacteria, viruses, and even fungi. [1] Currently, there are very few reports of EG caused by methicillin-resistant Staphylococcus aureus (MRSA), and even fewer cases caused by methicillin-sensitive Staphylococcus aureus (MSSA). [2] We present only the second case of bacteremic EG associated with MSSA bacteremia and aim to review the literature as well as examine common findings amongst patients with EG associated with Staphylococcus aureus.

2. Case Report

A 71-year-old male with a past medical history of stage IV small cell lung cancer with metastasis to the brain on chemotherapy presented to the emergency department with complaints of fever, diarrhea, and painful skin lesions on upper and lower lips as well as neck and right elbow. Carboplatin, etoposide, and atezolizumab were started approximately one week prior. His temperature on arrival at the hospital was 100.4oF, with labs revealing a white blood cell count of 0.6 × 10⁹/L, an absolute neutrophil count of 0.2 x 10⁹/L, and a platelet count of 30,000 x 10⁹/L.

A physical exam revealed four tender papules and plaques with surrounding induration and erythema around a necrotic center on the patient's upper and lower lips as well as on his right posterior elbow, left proximal palmar hand, and at the base of the second phalange on his left dorsal hand (Figure 1). Blood cultures were positive for methicillin-sensitive staphylococcus aureus (MSSA) in 2/2 sets. The patient was initially started on IV vancomycin and cefepime for suspected febrile neutropenia and bacteremia. Given the bacteremia and associated neutropenia, the patient's skin findings were suspected to be EG secondary to methicillin-sensitive Staphylococcus aureus bacteremia. Throughout the patient's hospital course, the patient's neutropenia and skin lesion began to improve, and thus, a skin biopsy was forgone. The patient was ultimately de-escalated to IV cefazolin and discharged home.

Given this patient's neutropenia, typical skin lesions, and MSSA bacteremia, MSSA bacteremia EG was the most likely diagnosis. However, other EG-associated pathogens were also considered in the differential diagnosis. Noninfectious causes such as autoimmune vasculitis, pyoderma gangrenosum, septic emboli, calciphylaxis, and disseminated intravascular coagulation were also considered.

Figure 1. The initial presentation revealed papules with surrounding induration and erythema around a grey-black necrotic center on the right posterior elbow (a), left proximal plantar hand (b), and at the base of the second phalange on his left dorsal hand (c)

3. Discussion

EG is a rare cutaneous infection most commonly associated with P. aeruginosa. Although P. aeruginosa has been identified in up to 75% of EG cases, other organisms have been reported, such as MRSA, streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae, fungi, and viruses. [1] Our patient presented with MSSA-associated EG, an organism not often thought of when a patient presents with EG. We completed a PubMed review between 1966 and 2022, using keywords of ecthyma gangrenosum, Staphylococcus aureus, methicillin-sensitive, and methicillin-resistant (Table 1). [2-12] We found only eleven cases of Staphylococcus aureus-associated EG, with only four reported cases of MSSA. The median age of patients was 40 years old, and 45% of these cases were seen in women (5 cases).

EG lesions begin as painless, round erythematous macules and patches that evolve to become tender with a central gangrenous ulcer and gray-black eschar surrounded by erythema. Skin findings can progress rapidly from vesiculobullous to hemorrhagic lesions. [10] While EG can occur anywhere on the body, the most common locations are the gluteal/perineal area (57%), followed by the extremities (30%), the trunk (6%), and the face (6%). [1] Staphylococcus aureus-associated EG presents in similar locations, with 7 cases affecting the lower extremities, 5 affecting the trunk, 3 affecting upper extremities, 3 affecting the head/face, and 2 affecting the gluteal/perineal area.

In our case, the organism was found through blood cultures; however, a skin biopsy or culture was not obtained due to the significant clinical improvement following empiric antibiotic therapy. Of the eleven reported cases of EG associated with Staphylococcus Aureus, only two cases with positive blood cultures were noted, ten cases reported culture lesions positive for Staphylococcus Aureus, and five cases reported gram-positive cocci on skin biopsy. The diagnosis of EG is made clinically based on the characteristic appearance and a high degree of clinical suspicion with blood cultures, tissue cultures, and a biopsy supporting the diagnosis. [13] Thus, given the risk factors found in this patient, MSSA bacteremia, and characteristic skin findings, he was diagnosed clinically with EG. However, it can not be ruled out that this patient's EG was unrelated to the MSSA bacteremia and that another non-bacteremic pathogen caused the EG.

Immunocompromised individuals are particularly susceptible to EG, with up to 62% to 75% of affected individuals having an underlying immunodeficiency. [13] Predisposing conditions include neutropenia, malignancy, diabetes mellitus, malnutrition, and burn wounds. [13] This patient fits the typical predisposing factors given his history of small cell lung malignancy, chemotherapy, and neutropenia. Predisposing factors we found common amongst Staphylococcus aureus-EG include other forms of malignancy (2 cases), history of chemotherapy (2 cases), and CKD (2 cases). Interestingly, three patients had past medical histories that would not support the clinical picture for EG, which included COPD and chronic alcohol use, with one patient having no significant past medical history. Common lab findings amongst Staphylococcus aureus-EG include neutropenia (3 cases), leukocytosis (3 cases), and leukopenia (2 cases).

EG is separated into two groups based on pathogenesis, bacteremic and non-bacteremic, with the bacteremic form being more common. In bacteremic EG, skin findings are the result of the hematogenous spread of a causative organism to the skin, subsequently leading to perivascular invasion causing ischemic necrosis of the surrounding skin. [13] In the non-bacteremic form, localized infections by organisms release toxins and enzymes, causing localized skin and vascular destruction. [13] While bacteremic EG is considered to be more common, we found only two other cases of bacteremic Staphylococcus aureus-EG, one case being MRSA associated and the other MSSA, which may seem counterintuitive given that Staphylococcus aureus is known to often spread hematogenously and is the most common cause of gram-positive bacteremia. [12,14,15] Thus, this case represents only the second MSSA bacteremia EG. While our patient was discharged home, the two other cases of bacteremic Staphylococcus aureus-EG died from sepsis and multiple organ failure. Furthermore, all of the patients with non-bacteremic Staphylococcus aureus-EG were discharged home. Thus, bacteremic-associated Staphylococcus aureus-EG may carry a higher risk of death, and our patient appears to be the only person to have survived this.

Table 1. Characteristics of patients diagnosed with Staphylococcus Aureus-associated EG. (a. Two rounds of hyper-CVAD (cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone). b. 5-fluorouracil, cisplatin, and trastuzumab. c. Carboplatin, etoposide, and atezolizumab)

Broad-spectrum antibiotics should be initiated following cultures in patients with suspected EG with narrowing of antibiotics following identification of antimicrobial susceptibilities. [13,16] This patient was successfully treated with IV vancomycin and cefepime and was later de-escalated to IV cefazolin. Of the eleven cases we found from the literature review, six were treated with vancomycin, and four were treated with cefepime. Other antibiotics we found commonly used were amikacin (3 cases), linezolid (2 cases), nafcillin (2 cases), and teicoplanin (2 cases).

4. Conclusion

While P. aeruginosa is the most common etiology of EG, although rare, other infectious pathogens should be considered in the differential, such as Staphylococcus aureus. This case is unique as it represents only the second case of EG due to MSSA bacteremia and the only case to have survived bacteremic-associated Staphylococcus aureus-EG. Thus, a history of immunosuppression, early culturing, and a high degree of clinical suspicion is necessary when considering rare etiologies of EG.

References

[1]   | Vaiman M, Lazarovitch T, Heller L, Lotan G. Ecthyma gangrenosum and ecthyma-like lesions: review article. Eur J Clin Microbiol Infect Dis. 2015; 34(4): 633-639.
[2]   | Fang KC, Lin FJ, Chen CH, et al. Ecthyma Gangrenosum Secondary to Methicillin-Sensitive Staphylococcus aureus in an Atopic Child with Transient Neutropenia: A Case Report and Review of the Literature. Diagnostics. 2022; 12(7): 1683.
[3]   | Şen H, İnangil G, Şahin L, Dere K, Özkan S, Dağli G. Ecthyma-gangrenosum-like lesions associated with methicillin-resistant Staphylococcus aureus infection. Int J Infect Dis. 2009; 13(4): e173-e175.
[4]   | Pechter PM, Marchione R, Milikowski C, Berman B. Ecthyma gangrenosum secondary to Staphylococcus aureus in an infant with transient neutropenia. Pediatr Dermatol. 2012; 29(3): 320-323.
[5]   | Chang AY, Carlos CA, Schuster M, Xu X, Rosenbach M. Nonpseudomonal ecthyma gangrenosum associated with methicillin-resistant staphylococcus aureus infection: a case report and review of the literature. Cutis. 2012; 90(2): 67-69.
[6]   | Jaque A, Moll-Manzur C, Dossi MT, Berroeta-Mauriziano D, Araos-Baeriswyl E, Monsalve X. [Ecthyma gangrenosum caused by Staphylococcus aureus]. Rev Chilena Infectol. 2016; 33(3): 336-339.
[7]   | Barry M, Alhijji A, Alsubaie A. Ecthyma gangrenosum secondary to MRSA in a young patient with chronic kidney disease. IDCases. 2021; 23: e01026.
[8]   | R G S, Muralidhar V. Non-pseudomonal ecthyma gangrenosum caused by methicillin-resistant Staphylococcus aureus (MRSA) in a chronic alcoholic patient. BMJ Case Rep. 2017; 2017.
[9]   | Song SS, Matiz C, Tom WL, Calame A, Krakowski AC, Friedlander SF. Ecthyma Gangrenosum-Like Lesions Secondary to Methicillin-Sensitive Staphylococcus aureus in an Immunocompetent Child. Pediatr Dermatol. 2015; 32(6): e259-e262.
[10]   | Ivanaviciene J, Chirch L, Grant-Kels JM, Kerr PE, Finch J. Ecthyma gangrenosum secondary to methicillin-sensitive Staphylococcus aureus. Int J Womens Dermatol. 2016; 2(3): 89-92.
[11]   | Ungprasert P, Permpalung N, Kue-A-Pai P, Ammannagari N, Chongnarungsin D. A rare case of ecthyma gangrenosum associated with methicillin-resistant Staphylococcus aureus infection. J Infect Chemother. 2013; 19(4): 761-763.
[12]   | Shah DJ, Leibowitz R, Salonia J. Ecthyma gangrenosum: A rare manifestation of staphylococcus aureus infection. Journal of Scientific Innovation in Medicine. 2021; 4(2).
[13]   | Shah M, Crane JS. Ecthyma Gangrenosum. In: StatPearls. StatPearls Publishing; 2022.
[14]   | Huminer D, Siegman-Igra Y, Morduchowicz G, Pitlik SD. Ecthyma Gangrenosum Without Bacteremia: Report of Six Cases and Review of the Literature. Arch Intern Med. 1987; 147(2): 299-301.
[15]   | Zhu Q, Yue Y, Zhu L, et al. Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study. Antimicrob Resist Infect Control. 2018; 7: 107.
[16]   | Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011; 86(2): 156-167.